The global vaccine delivery devices market is expected to witness an impressive growth attributed to increasing prevalence of medical infections and diseases. Consumption of vaccine delivery devices is significant in the healthcare industry due to increasing number of diabetic patients globally.
Syringes is expected to witness considerable demand among healthcare manufacturers as compared to other vaccine delivery devices in the global market.
Intramuscular route is expected to witness more preference as compared to other routes of administration in the global market by the end of 2022. North America is expected to represent the largest market for vaccine delivery devices in the global market throughout 2022.
Vaccine delivery devices is used for treatment of various medical diseases and infections. These are specialized devices that deliver a dose of drug or vaccine through a particular route of administration.
Vaccines delivery devices are also increasingly used among diabetic patients to inject doses of insulin such as Novorapid and Lantus.
A recently published report by Fact.MR reveals that the global vaccine delivery devices market is expected to register a healthy CAGR, and will represent a value of over US$ 4,000 Mn by the end of 2022.
Consumption in Healthcare Industry
Apart from injecting anesthesia before beginning with an operation, the vaccine delivery devices extend their application for various treatments in the healthcare industry. Healthcare professionals increasingly use vaccine delivery devices to inject medications in order to prevent prevalence of infections and diseases.
According to the centers for disease control and prevention (CDC), vaccination should be given during the period of birth and adulthood in order to maintain lifetime protection from several infections and diseases including influenza, meningitis, and hepatitis A and B.
Know More Details About the Report
Considerable Demand among Diabetic Patients
As diabetes type 1 and 2 have been increasingly prevalent among the geriatric population, vaccine delivery devices has been witnessing an upsurge in demand in the healthcare industry.
Healthcare professionals recommend patients who have brittle diabetes to inject certain doses of insulin such as Novorapid and Lantus regularly. Such factors have fuelled demand for vaccine delivery devices among the healthcare manufacturers.
Manufacturers are integrating developing technologies available in the market in order to offer vaccine delivery devices that are comparatively less painful.
A recent news update reveals that a new device has been developed ‘Microneedle Patches’, which is a needle-free injector and can inject a vaccine doze in a fraction of second. Bound to such factors, the global vaccine delivery devices market is expected witness a boost in growth during the predicted period.
Intramuscular Vaccine to Register Significant Growth
Syringes is expected to witness the highest revenue growth in the global vaccine delivery devices market. This segment is expected to represent a value of over US$ 900 Mn in the global market by the end of 2017.
North America is expected to remain the largest market for vaccine delivery devices globally. Jet devices is expected to witness the second highest revenue growth in 2017. Throughout 2022, syringes is expected to register the highest CAGR growth as compared to other products in the global market, followed by jet devices.
Intramuscular vaccine route of administration is expected to register the highest CAGR growth in the global vaccine delivery devices market, followed by subcutaneous route of administration.
The intramuscular vaccine route of administration is expected to witness the highest revenue growth in the global market. This segment is expected to represent a value of over US$ 1,000 Mn by the end of 2022. Subcutaneous route of administration is expected to represent the second highest revenue growth in the global vaccine delivery devices market during the predicted period.
Avail customized purchase options for your needs
Key market players operating in the global vaccine delivery devices market include
- Becton Dickinson & Company
- PharmaJet, Inc
- Valeritas Holdings Inc
- Vaxxas Pty. Ltd
- Gerresheimer AG
- Schott AG
- Antares Pharma, Inc
- 3M Company.
|Route of Administration||
(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)
Vaccine delivery devices witness a significant demand among the healthcare professionals attributed to growing prevalence of various medical infections and diseases. Growing prevalence of diabetes among the geriatric population is expected to fuel demand for vaccine delivery devices in the healthcare industry.
This Fact.MR report analyzes the expansion of global vaccine delivery devices market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The scope of Fact.MR’s report is to analyze the global vaccine delivery devices market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis.
Medical device manufacturers, research institutes, and raw material suppliers in the global vaccine delivery devices market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to vaccine delivery devices.
The report commences with a brief information of the global vaccine delivery devices market. This executive summary sets the tone for the rest of the report, providing users the scope of the report.
The executive summary includes important facts and statistics on the global vaccine delivery devices market.
The next section offers an overview of the global vaccine delivery devices market. This comprises an introduction to the market, along with a standard definition of the product – vaccine delivery devices.
In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.
The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.
In order to offer readers with up-to-date information about the latest advancements in the global vaccine delivery devices market, the report provides updates about market opportunities, which can benefit leading manufacturers of vaccine delivery devices.
With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for vaccine delivery devices manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.
The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global vaccine delivery devices market.
Product type, route of administration, and region are key segments that define the growth of the global market for vaccine delivery devices. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.
The report’s last section comprises of the global vaccine delivery devices market competitive landscape, to provide readers with the dashboard view of company analysis and market players.
This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global vaccine delivery devices market.
Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research.
We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,
- Primary research
- Secondary research
- Trade research
- Focused interviews
- Social media analysis
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.